HGF’s pharmaceutical practice brings together one of he largest and most talented collection of specialist patent attorney in Europe.  The majority of our attorneys have  advanced degrees and many years’ experience in large multinational pharmaceutical companies where they built, managed, commercialised and defended global patent portfolios for some of the most successful, high profile and improtant medicines around the world.

Our multidisciplinary team supports clients through all stages of the development and lifespan of pharmaceutical products. We specialise in providing IP strategy advice, patent prosecution, invention capture, drafting and filing patent applications, infringement analysis, EPO oppositions/appeals and, in conjunction with our IP litigators, multi-jurisdictional patent litigation for both owners and challengers. In addition to this we have specialist experience of supplementary protection certificates (SPCs), regulatory data exclusivity and IP due diligence. A large part of HGF’s pharmaceutical practice involves contentious proceedings and many of our experienced patent attorneys specialise in opposition and appeal proceedings before the European Patent Office. We are regularly involved with complex and high-value multi-party oppositions.

Our technical expertise covers drug compounds, particular forms of drug compounds (salt, solvates and polymorphs), formulations (including advanced drug delivery systems), processes for making drug compounds, methods of treatment and therapeutic uses (including drug repositioning), dosage regimens, combination therapies, drug conjugates (such as antibody drug conjugates and PROTACs) and neutraceuticals.